pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all- trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice

BLOOD CANCER JOURNAL(2015)

引用 1|浏览29
暂无评分
摘要
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all- trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
更多
查看译文
关键词
fusion genes,haematology,hemopoiesis,stem cells,immunology,apoptosis,therapy,oncology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要